Canada
Recordati Rare Diseases Canada Inc. is part of the Recordati Group, which was established in 1926 in Italy. The Recordati Group is a public global pharmaceutical company committed to the research and development of unique treatments for rare diseases and new medicines mainly for cardiovascular and urogenital disorders.
Recordati Rare Diseases is part of the rare diseases business within the Recordati Group, and is dedicated to developing innovative, high-impact therapies. Our focus is mainly on those who we believe need it most—people affected by rare diseases. They serve as our top priority and sit at the centre of everything we do.
Adverse events can be reported directly to Health Canada. For information on how to report to Health Canada, please visit the Adverse Reaction and Medical Device Problem Reporting page on Health Canada’s website.
Canadian Distributor
Mckesson Specialized Distribution
1-877-827-1306
(M-F 8:30 AM-5 PM ET)
Toll-Free
Products
Carbaglu® (carglumic acid dispersible tablets)
Cosmegen® (dactinomycin for injection)
Cystadane® (betaine anhydrous powder for oral solution)
Cystadrops® (cysteamine ophthalmic solution)
Panhematin® (hemin for injection)
Signifor® LAR (pasireotide for injectable suspension)
Signifor® (pasireotide injection)
Ledaga™ (chlormethine gel)
SYLVANT® (siltuximab for injection)
The Recordati Rare Diseases Patient Support Program Helps With:
Insurance Confirmation
Approval Checks
Medication Q & A
Coverage Research
Confirming if insurance companies will cover medication costs and understanding insurance plan benefits.
Researching alternative forms of medication coverage, or getting referrals to other possible sources of funding.
Insurance Confirmation
Confirming if insurance companies will cover medication costs and understanding insurance plan benefits.
Approval Checks
Working with doctor’s offices and insurance companies if additional approvals are needed.
Medication Q & A
Answering any questions related to accessing medications.
Coverage Research
Researching alternative forms of medication coverage, or getting referrals to other possible sources of funding.